NCT06112847View on ClinicalTrials.gov

Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

July 17, 2026

Study Completion Date

July 17, 2026

Conditions
Follicular Lymphoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Bone Marrow Biopsy

Undergo bone marrow biopsy

PROCEDURE

Computed Tomography

Undergo CT or PET/CT

OTHER

Electronic Health Record Review

Ancillary studies

BIOLOGICAL

Epcoritamab

Given SC

DRUG

Lenalidomide

Given PO

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (2)

91010

RECRUITING

City of Hope Medical Center, Duarte

92618

RECRUITING

City of Hope at Irvine Lennar, Irvine

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER